Item 1A. Risk Factors
Item 1A. Risk Factors
Investing in our common stock involves a high degree of risk. Before
you invest you should carefully review our Management’s Discussion and Analysis of Financial Condition and Results of Operations
set forth in Item 2 of Part I of this Quarterly Report on Form 10-Q, our consolidated financial statements and related notes included
in Item 1 of Part I of this Quarterly Report on Form 10-Q and our consolidated financial statements and related notes, as well as our
Management’s Discussion and Analysis of Financial Condition and Results of Operations and the other information in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2024. Readers should carefully review risks described in other documents we file from
time to time with the Securities and Exchange Commission.
We are currently not in compliance with the Nasdaq continued
listing requirements. If we are unable to regain compliance with Nasdaq’s listing requirements, our securities could be delisted,
which could affect our common stock’s market price and liquidity and reduce our ability to raise capital.
On May 6, 2025, the Company was notified by the Listing Qualifications
Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Staff granted the Company’s request
to transfer the listing of its common stock, par value $0.0005 per share (the “Common Shares”), from The Nasdaq Global Select
Market tier to The Nasdaq Capital Market tier, and that the Staff granted the Company’s request for a second 180-calendar day period,
or until November 3, 2025 (the “Second Compliance Period”), to regain compliance with the $1.00 bid price requirement, as
set forth in Nasdaq Listing Rule 5550(a)(2). To regain compliance with such minimum price requirement, the Company must evidence a closing
bid price of at least $1.00 per share for a minimum of 10 consecutive business days. The transfer of the listing of the Common Shares
from The Nasdaq Global Select Market to The Nasdaq Capital Market took effect with the open of business on May 8, 2025. The transfer is
not expected to impact trading in the Common Shares, which will continue to trade on Nasdaq under the symbol “GURE.”
As previously announced, on November 5, 2024, the Staff notified the
Company that the bid price for the Common Shares had closed below $1.00 per share for 30 consecutive business days and, as a result, the
Company no longer satisfied Nasdaq Listing Rule 5450(a)(1), the minimum bid price requirement applicable to The Nasdaq Global Select Market
issuers. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was afforded an initial 180-calendar day grace period, through May
5, 2025, to regain compliance with the minimum bid price requirement.
Issuers listed on The Nasdaq Global Select Market are not eligible
for a second 180-day grace period under the Nasdaq Listing Rules. However, based upon the Company’s compliance with the various
criteria required under Nasdaq Listing Rule 5810(c)(3)(A)(ii) to obtain a second 180-day grace period applicable to issuers listed on
The Nasdaq Capital Market, the Company applied to transfer the listing of its Common Shares to The Nasdaq Capital Market. As noted above,
the Staff approved the Company’s transfer application on May 6, 2025.
The Company intends to closely monitor the closing bid price for its
Common Shares and consider all available options to timely remedy the bid price deficiency. If at any time during the Second Compliance
Period, the closing bid price of the Common Shares is at least $1.00 per share for a minimum of 10 consecutive business days, the Staff
will provide the Company with written confirmation of compliance and the matter will be closed, unless the Staff exercises its discretion
to extend this ten-day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H).
The Company can give no assurance that it will regain or demonstrate
compliance during the Second Compliance Period. If the Company is not able to demonstrate compliance with the minimum bid price requirement
by November 3, 2025, or the Company does not comply with the terms of the extension, the Staff will provide written notification to the
Company that the Common Shares will be delisted. At that time, the Company may appeal the Staff’s determination to the Nasdaq Hearings
Panel (the “Panel”). The Company’s appeal request would stay any delisting action by the Staff at least pending a hearing
before the Panel and the expiration of any extension that may be granted by the Panel to the Company following the hearing.
The Company has provided written notice to Nasdaq of its intention
to cure the deficiency during the Second Compliance Period by effecting a reverse stock split, if necessary.
42
Item 2. Unregistered Sale of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.